Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma

BACKGROUND: despite the fact that the combination of gemcitabine (GCB) and docetaxel shows an increased benefit for disease-free survival and overall survival compared to GCB alone in patients with soft-tissue sarcoma, GCB mono-chemotherapy should be considered as a preferable option with respect to...

Descripción completa

Detalles Bibliográficos
Autores principales: De Pas, T, Spitaleri, G, Vigna, PD, Toffalorio, F, Curigliano, G, Gambino, A, Boselli, S, Catania, C, de Braud, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2008
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234072/
https://www.ncbi.nlm.nih.gov/pubmed/22275981
http://dx.doi.org/10.3332/ecancer.2008.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234072/
https://www.ncbi.nlm.nih.gov/pubmed/22275981
http://dx.doi.org/10.3332/ecancer.2008.102

Ejemplares similares